<div id="readability-page-1"><p>In a report released today, Milo Ferris from Ord Minnett maintained a Buy rating on Qoria, with a price target of <span id="expert-recommendation-target">A$0.56</span>.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>Ferris covers the Technology sector, focusing on stocks such as Qoria, Technology One Limited, and DUG Technology Ltd. According to TipRanks, Ferris has an average return of <span>-12.8%</span> and a 38.46% success rate on recommended stocks. </p> <p>In a report released on April 26, Bell Potter also maintained a Buy rating on the stock with a A$0.50 price target.</p></div>

159316

159892

<p>Ord Minnett analyst Milo Ferris has reaffirmed a Buy rating for Qoria (FMZNF), setting a price target of A$0.56. Ferris, who specializes in the Technology sector, has an average return of -12.8% and a 38.46% success rate on his stock recommendations. Additionally, Bell Potter also maintains a Buy rating for Qoria with a price target of A$0.50, as reported on April 26.</p>

Tip Ranks

E Fund Hang Seng SCHK Innovative Drug ETF

BlackRock, Inc.

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Invesco Biotechnology & Genome ETF

E Fund CSI 300 Health Care ETF

SPDR S&P Biotech

Bosera Hang Seng Health Care ETF(QDII)

Guotai CSI Bio-medicine ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Proshares Ultra Nasdaq Biotech

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC SSE STAR Biology and Medicine ETF

iShares US Pharma

China Merchants CSI Biotechnology Theme ETF

ALPS Medical Breakthrough

Ark Genomic Revolution ETF

iShares Biotechnology ETF

E Fund CSI Biotechnology Theme ETF

Technology One Limited

DUG Technology Ltd

Ord Minnett Sticks to Its Buy Rating for Qoria (FMZNF)